Remove science oncology-cancer patient-centricity-white-paper
article thumbnail

Meet the company on a mission to transform research and advance healthcare

Pharmaceutical Technology

Meanwhile, in clinical trials with available race data, white participants account for 59% of trial subjects, more than the combined total for all other racial categories. participation of white subjects. In addition, safety oncology and immunotherapy, which is a focus area for Cerba Research has close ties to virology.

Research 130
article thumbnail

Cerba Research and Teddy Lab sign Memorandum of Understanding on entering into a discussion for Joint Venture

Pharmaceutical Technology

Teddy Lab has been a trusted partner for many years and mirrors our commitment to high-quality, patient-centric solutions. About Cerba Research : We offer world-class clinical research that helps life science companies to successfully develop the predictive and precision medicines of the future.

Research 130